Skip to main content
. 2020 Sep 16;4(1):e000735. doi: 10.1136/bmjpo-2020-000735

Table 2.

Demographic and clinical findings of patients with and without snakebite sequelae

No sequelae n=50 With sequelae n=24 P value
Age, months (range) 113 (67.3–130.5) 110 (73–130.8) 0.87
Male gender 34 (68)* 18 (75)* 0.59
Anatomical site of the bite 0.43
 Lower extremities 33 (66) 14 (58)
 Upper extremities 14 (28) 10 (41.6)
 Head 2 (4) 0
 Chest 1 (2) 0
 Severity of envenoming 0.095
 Mild 13 (26) 3 (12.5)
 Moderate 36 (72) 18 (75)
 Severe 1 (2) 3 (12.5)
Time to medical evaluation, hours (range) 2.0 (1.0–9.0) 2.0 (1.25–5.5) 0.76
Time to administration of antivenom, hours (range) 2.0 (1.0–15.0) 2.0 (1.0–6.0) 0.84
Initial signs and symptoms
 Pain 37 (74) 17 (70.8) 0.78
 Local oedema 47 (94) 24 (100) 0.54
 Bleeding 14 (28) 10 (41.6) 0.29
 Bullae formation 5 (10) 4 (16.7) 0.46
 Local necrosis 0 2 (8.3)
Acute complications presented during hospitalisation†
 Infection 3 (6) 9 (37.5) 0.0013
 Serum sickness 2 (4) 1 (4.2) >0.99
 Compartmental syndrome 16 (32) 20 (83.3) <0.0001
Need of fasciotomy 17 (34) 21 (87.5) <0.0001

Categorical data are expressed as frequencies (%) and analysed using Fisher or χ2 test.

Continuous data are expressed as median (25%–75% interquartile range) and analysed using Mann-Whitney rank test or Student’s t-test.

Values in bold indicate significant two-sided p values.

*Results are presented as number of patients and percentages (in parentheses).

†Acute complications presented during hospitalisation refers to those complications presented during the initial days after snakebite, and not to long-term complications.